Three U.S. Senators say they are "alarmed" Novo Nordisk discontinued U.S. sales of a popular insulin brand and are demanding answers from the pharmaceutical giant they say left patients without an affordable substitute.
What impact, if any, will this have on Novo Nordisk, or other manufacturers that decide to orphan a drug? And will NN continue to manufacture the drug (same/different brand name) and only distribute it outside the US?
Senators demand answers from drugmaker about discontinuation of popular insulin Levemir
Three Senate Democrats are demanding answers from Novo Nordisk over its decision to discontinue Levemir, which is FDA-approved for pregnancy.
www.usatoday.com
What impact, if any, will this have on Novo Nordisk, or other manufacturers that decide to orphan a drug? And will NN continue to manufacture the drug (same/different brand name) and only distribute it outside the US?